Aggregate Value of Trade Sales of VC-Backed BioPharma Companies

Trends

“…while the number of VC-backed M&A exits is in line with prior years (~25 per year), the value both in terms of upfront and full “biobuck” (~milestones) potential have reached new highs, topping over $5 and $8 billion, respectively.”

Aggregate Value of Trade Sales of VC-Backed BioPharma Companies“…the average values per deals are steadily escalating – even though the average invested capital required to get there has remained steady.”

Average Deal-Specific Values of Trade Sales of VC-Backed BioPharma Companies

“…these trends have led to a very robust and positive return trend. Return multiples have almost tripled since 2005-2007 on overall deal multiples, and have more than doubled on the upfront multiples.”

Estimate of Weighted-Average Returns

Source: Bruce Booth, “Data Snapshot: VC-Backed BioPharma M&A 2014,” Forbes, 2/3/15

Learn about SJA Business Development Services.